Investing.com -- AstraZeneca (LON:AZN) has announced that its experimental precision drug has shown improvement in slowing the progression of lung cancer in a late-stage trial,...
By Nikolaj Skydsgaard COPENHAGEN (Reuters) -A thyroid cancer safety signal was raised by the EU's drugs watchdog last month over several Novo Nordisk (CSE:NOVOb) products...
Proactive Investors - AstraZeneca PLC (LON:AZN) is placing an US$85mln bet on the autoimmune cell therapy sector with Quell Therapeutics - its latest licensing partner. As well as...
Sharecast - The FTSE 100 pharmaceuticals giant said the approval was based on a subgroup analysis conducted during the phase three ‘PROpel’ trial. It said the analysis...
Proactive Investors - AstraZeneca PLC (LON:AZN) has hailed the potential of a highly targeted combination of its own drugs with chemotherapy in the battle against endometrial...
Sharecast - The FTSE 100 pharmaceuticals giant said the combination had the potential to significantly improve progression-free survival (PFS) in patients with locally-advanced or...
Investing.com - European stock markets traded in a mixed fashion Thursday, as investors digested a deluge of corporate earnings, with the banking sector in particular focus. At...
54 to 64 bullish sentiments again volatility trading
0
$68 in 1 month
4
Do you this will grow as EU has approved their Covid vaccine?
0
will reach 100 in 6 months time
0
I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E